From 24 to 26 October 2023, we’ll be in Abuja, Nigeria, for the third Africa Hepatitis Summit. The conference will bring civil society organizations, policymakers, global funders, medical professionals, and other stakeholders under the theme “Putting Africa on Track towards Viral Hepatitis Elimination”. Confirmed conference speakers include our Executive Director, Finn Jarle Rode, and our[…..]
News
INHSU 2023 – The 11th International Conference on Health and Hepatitis in Substance Users
From 18 to 20 October 2023, we’ll be at INHSU 2023 in Geneva. Hosted by INHSU – the International Network on Health and Hepatitis in Substance Users – the conference will bring together over 800 people from over 50 countries working in the fields of harm reduction, infectious diseases, drug policy and more. Co-conveners of[…..]
APAC Liver Disease Alliance White Paper launch
On 18 July at 9 AM CEST/3 PM SGT, our Partnerships and Programme Director, Capucine Pénicaud, will join an expert panel for the online launch of the first White Paper of APAC Liver Disease Alliance with the title “Eliminating Asia’s Silent Emergency: Hepatitis and Hepatocellular Carcinoma”. The APAC Liver Disease Alliance was officially launched in January 2023.[…..]
THF at the Africa Health ExCon
From 6 to 9 June, we will be in Cairo at the Africa Health ExCon, the largest Medical Conferences and Exhibition in Africa. On Wednesday, 7 June, our Executive Director, Finn Jarle Rode, will chair the “Investors and Funders for International Cooperation – Resources and Lessons from the Pandemic” session with speakers from the African[…..]
THF at the Global Hepatitis Summit 2023
From 25 to 28 April 2023, we will be in Paris at the Global Hepatitis Summit 2023 (the 18th International Symposium on Viral Hepatitis and Liver Disease – ISVHLD). On Thursday, 27 April (8.30 – 10.30), our Senior Grant Manager, Maria Carolina Salazar, will join the WHO Symposium “Viral hepatitis elimination – What’s new, what’s[…..]
Statement: The Hepatitis Fund (THF) today warmly welcomed the announcement by Unitaid of US$ 31 million to fund three new consortia charged with working to more effective prevention of hepatitis C (HCV) infection amongst people who inject drugs and prisoners.
Nearly 40 per cent (six million) of people who inject drugs globally are currently living with hepatitis C. But less than 10 per cent of those who need it have accessed treatment. “We need creative programmes that are capable of reaching the most vulnerable with those drugs we know can cure the disease,” said Helen[…..]
HR23 pre-conference on viral hepatitis and harm reduction
On 15 April, our Programme and Partnership Director, Capucine Penicaud, will be in Melbourne for the HR23 pre-conference on viral hepatitis and harm reduction. He will join a panel of experts, including representatives from CHAI, INPUD, The Global Fund to fight AIDS, Tuberculosis and Malaria and Harm Reduction International, to discuss the financial landscape around[…..]
New partnership with Muslim World League
We’re pleased to share that we started a new partnership with the Muslim World League (WML). WML is supporting our efforts as part of its involvement in global health. WML is an engaged supporter of health-related initiatives and, in recent years, implemented various programmes that provided healthcare to more than one million people. We believe[…..]
The latest news in viral hepatitis elimination.
The Hepatitis Fund first Activity Report has been released on World Hepatitis Day 2021. Find it here. How can the world end viral hepatitis by 2030? 5 experts explain. Read Manal El-Sayed blog post contribution for WHD 2021 here. Financing the elimination of viral hepatitis. Watch this World Economic Forum and Hepatitis Fund roundtable, in cooperation[…..]
Pakistan announces a new ambitious plan to eliminate viral hepatitis by 2030
On World Hepatitis Day, the Government of Pakistan announced a new ambitious plan by the Prime Minister to eliminate viral hepatitis by 2030. The plan was unveiled by Dr Zafar Mirza, Special Assistant to the Prime Minister, and aims to scale up hepatitis prevention, testing and treatment services by screening up to 140 million people in[…..]